NCT06149065View on ClinicalTrials.gov

Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

CompletedOBSERVATIONAL
Enrollment

247

Participants

Timeline

Start Date

June 5, 2021

Primary Completion Date

June 6, 2023

Study Completion Date

June 6, 2023

Conditions
AcneTransgenderism
Interventions
DRUG

Testosterone

Masculinizing hormone therapy (testosterone) is used in female-to-male transgenders for medical reason.

Trial Locations (1)

10400

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchathewi

All Listed Sponsors
lead

Mahidol University

OTHER